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ABSTRACT 
 
Polymorphonuclear neutrophils (PMN) participate in an active way in the innate immunity developed after the fungal 
infection paracoccidioidomycosis (PCM). Nevertheless, the sole participation of neutrophils is not sufficient to eradicate 
PCM`s pathogenic fungus: Paracoccidioides brasiliensis (Pb). In that way, we aimed to develop a treatment capable of 
stimulating PMN to the site of injury through low-level laser therapy (LLLT). (LLLT) is safe to use and has not been 
linked to microorganism resistance so far; in addition, based on previous studies we understand that LLLT may be useful 
to treat several medical conditions through the stimulation and activation of certain types of cells. This brief review is 
based on the novel attempt of activating PMN against a fungal infection. 
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INTRODUCTION 
 
This is a review about recently obtained data that were presented at the SPIE BiOS Photonics West; the data 
have been sent out for publication and it was accepted for publication in another journal 1. In that way, this present 
manuscript aims only to present the basis of such novel approach and why we believe it may be successful for combating 
infections such as paracoccidioidomycosis (PCM), which is caused by Paracoccidioides brasiliensis (Pb).    
New inflammatory cell populations have been revealed to play central roles in the immune response against 
fungi, namely Th17, Th22 and Th9 cells 2. These inflammatory cells stimulate endothelial and epithelial cells, as well as 
macrophages to produce cytokines and chemokines as IL-1β, IL-23, IL-6 and antimicrobial peptides as defensines; these 
metabolites induce, instead, the gathering of PMN, which pose as important players at the fungal infection control 3. 
Nevertheless, the sole contribution of PMN or other inflammatory cells is not sufficient to eradicate an 
important fungal infection like PCM 4. In fact, the main protective mechanisms in systemic mycosis as PCM are CD4 T, 
CD8 T cells and macrophages activated by a plethora of cytokines, mainly of the Th1 lineage. But even with innate and 
acquired immune mechanisms acting in concert the immune reaction of the patient needs to be supplemented with 
antifungal drugs that are often harmful to the organism 4, 5, especially if used for long periods of time. In addition, the 
continuous use of drugs may induce resistance by the targeted microorganism (Pb generally presents resistance through 
increased melanization 5).  
Interestingly, low-level laser therapy (LLLT) and even the so-called antimicrobial photodynamic therapy 
(aPDT) are safe to use and have not been linked to microorganism resistance so far. This fact surely opens a wide field of 
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medical applications for both the aforementioned techniques, especially at the present moment, when we face highly 
resistance bacteria emerge due to the raise of antibiotics intake.  
In that way, a novel technique comprising the stimulation of competent neutrophils through LLLT to help them 
combating Pb is indeed stimulating. 
 
PARACOCCIDIOIDOMYCOSIS 
 
PCM is a fungal infection caused by Pb, a dimorphic fungus that can assume either a mycelium or a yeast form; 
Pb is transmitted to humans primarily through inhalation of the fungi and leads to lung infection 6. PCM infection can be 
divided into two main types: acute (juvenile) and chronic (adult) 7, 8. The majority of cases fall in the chronic form 6, 9. 
A characteristic of this form of the disease that renders it extremely difficult to diagnose is the gamut of clinical 
aspects that it presents. In fact, a technical report compiled by the main authorities in the clinical aspects of PCM has 
been published 10. These authors classified the disease in: PCM-infection, PCM-disease, acute/subacute form (juvenile), 
chronic form (adult), unifocal (only one organ involved), multifocal (more than one organ involved), residual or sequelar. 
In the adult forms, the lungs are involved in almost all patients, but oral manifestations are also common. 
Actually, mucosa from the oral cavity, pharynx and larynx are affected in a high percentage of chronic PCM 
patients; regarding to the oral mucosa, PCM lesions may resemble the appearance of a squamous cell carcinoma, once it 
comprises a superficial ulcer often referred as (mulberry-like stomatitis) 11.  In order to discard the possibility of cancer, 
an incisional biopsy should be performed; also, concomitantly to the histopathological analysis PCM can be confirmed 
with chest X-rays and serological exams. 
Still concerning to the incisional biopsy that should often be performed, distinct microscopic features may 
appear and then can help to differentiate a classic PCM lesion from oral cancer (Figure 1). First of all, PCM occurs 
along a usual granulomatous inflammatory reaction that comprises numerous granulomas (histiocytes, lymphocytes, 
macrophages and other cells organized in circular patterns) around PCM`s pathogenic agent: Pb. This specialized 
inflammatory reaction is one of the main features that makes PCM`s histological appearance distinct from a neoplasia. 
Actually, oral squamous cell carcinoma (OSCC) is often related to a chronic inflammation mostly composed by 
lymphocytes and plasmocytes; however, the neoplastic infiltrate appears as a solid, discrete to moderate/intense, diffuse 
inflammation (markedly different from the granulomatous architecture) 12. 
The ulcer, on the other hand, is a common character between PCM and OSCC lesions. Accordingly, the 
microscopic evaluation will reveal a discontinued oral squamous epithelium covering the connective tissue in both 
lesions. The OSCC epithelium, however, will be dysplasic and evidenced by the presence of several pleomorphic 
keratinocytes exhibiting hypercromatism, augmented nucleoli, higher nucleus/cytoplasm ratio and even variable 
incidence of atypical mitoses. In addition, highly differentiated OSCCs often present keratin pearls throughout the lesion, 
which surely helps differentiating it from a Pb infection. Instead, PCM shows a distinct epithelium bordering the ulcer; 
this epithelium is classified as a pseudo-carcinomatous epithelium. The reason for that classification is the fact that this 
epithelium migrates towards the connective tissue through long hyperplasic projections; nevertheless, although 
mimicking a neoplasic epithelium, its cells do not detach one from another and the epithelium does not invade the 
subjacent tissue 12.    
All the characteristics detailed above can be simply detected with the help of an optical microscope and the 
easy-to-perform hematoxylin and eosin (HE) staining. Still through an HE stained section, the yeast-like form of Pb can 
be spotted within the lesion (it has a thick cell wall and often presents the emerge of narrow base budding cells). 
Nevertheless, some lesions do not present a high burden of fungi, demanding more specific techniques to help localizing 
the yeasts throughout the tissue. These techniques comprise simple histochemical methods such as the PAS (Periodic 
Acid-Schiff) 13 and the Grocott-Gomori methenamine-silver stain 14, 15;  An even more specific approach would be to use 
immunohistochemical reactions based on an anti-Pb primary antibody (usually obtained from the São Paulo Institute of 
Tropical Medicine, São Paulo, Brazil) at a dilution of 1:200.000. 
Although PCM infection appears mainly in Latin America 16, especially in Brazil (high indexes of infection for 
the Southeastern population 17), PCM can also sporadically happen in distant regions; in these particular cases, PCM 
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often raises from people who have previously visited endemic areas 18. As the signs and symptoms of the disease may 
take even more than 10 years to appear 18, PCM poses as a difficult and challenging diagnose in this situation.  
  In addition, establishing the diagnosis of PCM may be difficult due to the inconstant serologic results found 
within chronic patients. One of the widely used serologic test for PCM is DID using the exoantigen from Pb339 19; the 
test is based on detecting serum antibodies against Pb, showing a high sensitivity and specificity and also being cheap 
and easy to perform 19, 20. However, when examining the serum of PCM patients, the predominant levels of detected 
antibodies vary between low and moderate 21, 22, whereas the chronic form is regularly linked to low levels 20 and the 
acute form is associated to high levels usually 21. 
 In that way, following previous serological results it was concluded that cellular primary immune response is 
favored against the humoral response against Pb 23. Actually, the activation of phagocytic cells mediated through Th1-
type mechanisms is indeed related to resistance against this fungus 24-26, while the stimulated humoral response elicited 
by Th2-type means supports the persistence of the disease 24, 27.  
 Essentially, there is a need for the co-participation of Th1 and Th2 response to better deal with PCM 28, 29, but as 
said the cellular immune response really poses as a determinant factor in the pathogenicity of this fungal infection. In 
that way, triggering neutrophils to exert such primary killing abilities should be effective. In fact, neutrophils do possess 
fungicidal capabilities in terms of phagocytosis and the release of reactive oxygen species (ROS); is somehow stimulated, 
these capabilities could be handful while emerged in a fungal infection scenario. 
 
NEUTROPHIL ACTIVATION 
 
 As previously mentioned, the PMN phagocytic capacity is truly important for combating infections, in 
particular PCM. Actually, PMN from healthy humans can phagocyte the Pb straightaway 30, what led to questioning if 
the PMN from PCM patients had any kind of deficiency that would impair them to fight the fungus; interestingly, these 
studies were able to demonstrate that the capacity of phagocyting and destroying Pb is really compromised in patients 
suffering from PCM 31-34. 
 So, this is another important reason that support the relevance of “activating” PMN in order to help them 
dealing with PCM. This hypothesis of PMN activation for higher fungicidal capacity is not entirely new, being 
previously showed with the improved activity of PMN against Candida spp. and Blastomyces dermatitidis in vitro 
following an intraperitoneal injection of homologous antigen in B. dermatitidis-immune mice 35. An improved 
microbicidal activity of PMN was also achieved after sensitizing spleen cells with a specific antigen; this sensitization 
was efficient to activate PMN 36. 
Actually, the activation of PMN depends o several factors that occur during an inflammatory reaction. Recently, 
it was shown that natural killer (NK) cells directly modulate neutrophil functions 37. As described earlier, PMN are also 
activated through direct contact with dendritic cells 38 and even T cells 39; PMN can also be activated by cytokines 
produced locally:Th17 cells, for instance, recruit PMN in a CXCL-8-dependent way, increasing their survival and 
expression of activation markers by releasing granulocyte macrophage colony-stimulating factor (GM-CSF), IFNγ and 
tumor necrosis factor (TNF) α 40. 
 More explicitly, Costantini et al. have shown that NK cells promote the survival of PMN in the presence of IL-2, 
IL-15, IL-18 or IL-15 plus IL-18; in addition, when exposed to these interleukins the NK cells up-regulated the 
expression of activation markers in PMN, and also triggered them to enhance the production of superoxide anion 37. Thus, 
the authors were able to demonstrate that NK cells immersed in an innate immunity or even in an adaptive immunity 
scenario could prolong the survival and modulate the functions of human PMN 37. 
 The activation of neutrophils is also crucial for the organism to establish an inflammatory reaction against 
Gram-negative bacterial infections and, as seen before, lipopolysaccharide (LPS) is an important mediator of neutrophil 
activation, together with an early down-regulation of L-selectin and up-regulation of CD1lb/CD18 41; on the other hand, 
a different study showed that lipoprotein (LP), which is the most frequent protein in the outer membrane of 
Enterobacteriaceae, can also activate human PMN, though through a different mechanism from that of LPS 41.  
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It is very interesting to see that cytokines and even other types of inflammatory cells can help PMN to apply its 
duties. We are convinced that by utilizing LLLT we can also induce PMN to act more actively even discharging higher 
amounts of ROS to kill Pb. 
 
 
LLLT FOR ACTIVATING CELLS 
 
 LLLT is a non-thermic and non-ionizing irradiation that has been opportunely used to trigger the metabolism of 
living cells, and by so leading to positive results such as enhanced cell proliferation in wound healing circumstances, and 
diminishment of pain and inflammation as well 42-44. 
 Accordingly, LLLT`s potential of stimulating different types of cells has generated several studies that came out 
to unravel the power of this light irradiation on different fields; one stimulating area that LLLT acts upon is traumatic 
brain injury (TBI). It is remarkable how the 810-nm light can improve TBI by stimulating neurogenesis and also 
reducing cell death when applied transcranially 45. This simple transcranial approach can also reduce neuroinflammation 
46. 
 Other studies have also shown how LLLT can accelerate wound healing by stimulating the migration of 
keratinocytes towards the wound to promote its closure 43. More specifically, LLLT can stimulate the keratinocytes to 
mature quicker, expressing higher amounts of cytokeratin 10 prior than the non-irradiated cells; in addition, LLLT 
promotes higher expression of proteins related to cell division, such as p63 and cyclin D1 44. 
 Still regarding to cell-cycle proteins, LLLT can enhance the expression of cyclin D1 in oral cancer cell lines; 
the irradiated cells also exhibited a more active profile, which was confirmed by an increased pAkt and pS6 expression 47. 
Moreover, although LLLT may act as a pro-inflammatory tool 48, 49, it can also produce anti-inflammatory effects 42, 50-52; 
it all depends on various conditions of the irradiated tissue, for example the availability or absence of antioxidants 53. 
Finally, drugs such as Itraconazole, which is constantly used to treat PCM, may undesirably lead to disease 
relapses; in fact, 50% of these recurrences may occur after a significant amount of time: 3 years 54. Conveniently, LLLT 
is a safe and non-invasive procedure that can apparently help PMN to deal with an infection, namely PCM (Figure 2). 
Besides, antifungal therapies often lead to adverse effects and even resistance, while LLLT has been never associated to 
neither of these questions. 
 
CONCLUSION 
 
Activating PMN with the help of LLLT may serve as a novel and promising approach against infections that are 
initially combated through innate immunity mechanisms 1, and in which this cell population directs the acquired immune 
response, namely PCM. Although antifungal drugs are reasonably effective, they may lead to several adverse effects and 
even resistance by the fungi. In that way, LLLT present some advantages over the traditional treatment for PCM. 
 
FIGURE CAPTIONS 
 
Figure 1. Histological appearance of A: Oral Paracoccidioidomycosis (note the arrow indicating a pseudo-carcinomatous hyperplasia 
of the epithelium adjacent to the ulcer); and B: Oral Squamous Cell Carcinoma (arrows point to keratin pearls within the dysplasic 
epithelium). In addition, A illustrates a prominent granulomatous inflammatory reaction, while B highlights a lymphocyte infiltrate 
subjacent to the epithelium (HE – 400X). 
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Figure 2. Low-power laser irradiation to activate fungicidal neutrophils. 1 – LLLT is performed in vivo on mouse femur to reach the 
bone medulla; 2 and 3 – blood of the femoral medulla contains activated neutrophils that are sorted; 4 – activated neutrophils are more 
reactive to Pb, releasing high amounts of ROS to inactive the fungus. 
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